A new report in the June issue of Clinical Cancer Research, says that antiestrogen drug hormone therapy given to women with ovarian cancer can extend their life expectancy. The UK-funded study of 44 women offers a first alternative to chemotherapy.

Related posts:

  1. Estrogen Therapy May Benefit Younger Women
  2. Cancer Care Inequality
  3. Is Red Wine the New Anti-Aging Drug?
  4. Tykerb: A New Cancer Drug Approved
  5. Prevalent Women’s Health Condition Affects 1 Out of Every 5 Women

|



Comments

Name (required)

Email (required)

Website

Leave a comment